Posterior talar process as a suitable cell source for treatment of cartilage and osteochondral defects of the talus

Bibliographic Details
Main Author: Correia, Sandra I.
Publication Date: 2017
Other Authors: Silva-Correia, Joana, Pereira, H., Canadas, Raphael Faustino, Morais, Alain, Frias, A. M., Sousa, R. A., van Dijk, C.N., Mendes, João Espregueira, Reis, R. L., Oliveira, J. M.
Format: Article
Language: eng
Source: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Download full: http://hdl.handle.net/1822/38337
Summary: Osteochondral defects of the ankle are common lesions affecting the talar cartilage and subchondral bone. Current treatments include cell-based therapies but are frequently associated with donor-site morbidity. Our objective is to characterize the posterior process of the talus (SP) and the os trigonum (OT) tissues and investigate its potential as a new source of viable cells for application in tissue engineering and regenerative medicine.SP and OT tissues obtained from six patients were characterized by micro-computed tomography, and histological, histomorphometric and immunohistochemical analyses. Isolated cells proliferation and viability were evaluated by MTS assay, DNA quantification and Live/Dead staining. The TUNEL assay was performed to evaluate cell death by apoptosis. Moreover, the production of extracellular matrix was evaluated by toluidine blue staining, whereas cells phenotype was investigated by flow cytometry. Ankle explants characterization showed the presence of a cartilage tissue layer in both SP and OT tissues, which represent, at least 20% in average of the explant. The presence of type II collagen was detected in the extracellular matrix. Isolated cells presented a round morphology typical of chondrocytes. In in vitro studies, cells were viable and proliferating up to 21 days of culturing. No signs of apoptosis were detected. Flow cytometry analysis revealed that isolated cells maintained the expression of several chondrocytic markers during culturing. The results indicate that the SP and OT tissues are a reliable source of viable chondrocytes, which can find promising applications in ACI/MACI strategies with minimal concerns regarding donor zone complications.
id RCAP_3676403c69356f52525d5e62e6fa2155
oai_identifier_str oai:repositorium.sdum.uminho.pt:1822/38337
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Posterior talar process as a suitable cell source for treatment of cartilage and osteochondral defects of the talusAnkleOs trigonumOsteochondral lesionsRegenerative medicineStieda processTalus lesionsCiências Médicas::Biotecnologia MédicaScience & TechnologyOsteochondral defects of the ankle are common lesions affecting the talar cartilage and subchondral bone. Current treatments include cell-based therapies but are frequently associated with donor-site morbidity. Our objective is to characterize the posterior process of the talus (SP) and the os trigonum (OT) tissues and investigate its potential as a new source of viable cells for application in tissue engineering and regenerative medicine.SP and OT tissues obtained from six patients were characterized by micro-computed tomography, and histological, histomorphometric and immunohistochemical analyses. Isolated cells proliferation and viability were evaluated by MTS assay, DNA quantification and Live/Dead staining. The TUNEL assay was performed to evaluate cell death by apoptosis. Moreover, the production of extracellular matrix was evaluated by toluidine blue staining, whereas cells phenotype was investigated by flow cytometry. Ankle explants characterization showed the presence of a cartilage tissue layer in both SP and OT tissues, which represent, at least 20% in average of the explant. The presence of type II collagen was detected in the extracellular matrix. Isolated cells presented a round morphology typical of chondrocytes. In in vitro studies, cells were viable and proliferating up to 21 days of culturing. No signs of apoptosis were detected. Flow cytometry analysis revealed that isolated cells maintained the expression of several chondrocytic markers during culturing. The results indicate that the SP and OT tissues are a reliable source of viable chondrocytes, which can find promising applications in ACI/MACI strategies with minimal concerns regarding donor zone complications.Portuguese Foundation for Science and Technology (FCT) through the project OsteoCart (Grant No. PTDC/CTM-BPC/115977/2009), Fundación MAPFRE (Ayudas a la Investigación Ignacio H. de Larramendi, Prevención, Salud y Medio Ambiente, Spain) under the project 'Preventing the progression of the knee osteoarthritis: advanced therapies combining injectable hydrogels, autologous stem cells and PRP' (Grant No. BIL/13/SA/235). This study was also carried out with the support of Fundo Europeu de Desenvolvimento Regional (FEDER) through Programa Operacional do Norte through the project Articulate (Grant No. 23189)WileyUniversidade do MinhoCorreia, Sandra I.Silva-Correia, JoanaPereira, H.Canadas, Raphael FaustinoMorais, AlainFrias, A. M.Sousa, R. A.van Dijk, C.N.Mendes, João EspregueiraReis, R. L.Oliveira, J. M.20172017-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/1822/38337engCorreia S. I., Silva-Correia J., Pereira H., Canadas R. F., da Silva Morais A., Frias A. M., Sousa R. A., Niek V. D. C., Espregueira-Mendes J. D., Reis R. L., Oliveira J. M. Posterior talar process as a suitable cell source for treatment of cartilage and osteochondral defects of the talus, Journal of Tissue Engineering and Regenerative Medicine, doi:10.1002/term.2092, 20171932-700510.1002/term.209226510640http://onlinelibrary.wiley.com/doi/10.1002/term.2092/abstractinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T12:18:02Zoai:repositorium.sdum.uminho.pt:1822/38337Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T19:10:45.716726Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Posterior talar process as a suitable cell source for treatment of cartilage and osteochondral defects of the talus
title Posterior talar process as a suitable cell source for treatment of cartilage and osteochondral defects of the talus
spellingShingle Posterior talar process as a suitable cell source for treatment of cartilage and osteochondral defects of the talus
Correia, Sandra I.
Ankle
Os trigonum
Osteochondral lesions
Regenerative medicine
Stieda process
Talus lesions
Ciências Médicas::Biotecnologia Médica
Science & Technology
title_short Posterior talar process as a suitable cell source for treatment of cartilage and osteochondral defects of the talus
title_full Posterior talar process as a suitable cell source for treatment of cartilage and osteochondral defects of the talus
title_fullStr Posterior talar process as a suitable cell source for treatment of cartilage and osteochondral defects of the talus
title_full_unstemmed Posterior talar process as a suitable cell source for treatment of cartilage and osteochondral defects of the talus
title_sort Posterior talar process as a suitable cell source for treatment of cartilage and osteochondral defects of the talus
author Correia, Sandra I.
author_facet Correia, Sandra I.
Silva-Correia, Joana
Pereira, H.
Canadas, Raphael Faustino
Morais, Alain
Frias, A. M.
Sousa, R. A.
van Dijk, C.N.
Mendes, João Espregueira
Reis, R. L.
Oliveira, J. M.
author_role author
author2 Silva-Correia, Joana
Pereira, H.
Canadas, Raphael Faustino
Morais, Alain
Frias, A. M.
Sousa, R. A.
van Dijk, C.N.
Mendes, João Espregueira
Reis, R. L.
Oliveira, J. M.
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade do Minho
dc.contributor.author.fl_str_mv Correia, Sandra I.
Silva-Correia, Joana
Pereira, H.
Canadas, Raphael Faustino
Morais, Alain
Frias, A. M.
Sousa, R. A.
van Dijk, C.N.
Mendes, João Espregueira
Reis, R. L.
Oliveira, J. M.
dc.subject.por.fl_str_mv Ankle
Os trigonum
Osteochondral lesions
Regenerative medicine
Stieda process
Talus lesions
Ciências Médicas::Biotecnologia Médica
Science & Technology
topic Ankle
Os trigonum
Osteochondral lesions
Regenerative medicine
Stieda process
Talus lesions
Ciências Médicas::Biotecnologia Médica
Science & Technology
description Osteochondral defects of the ankle are common lesions affecting the talar cartilage and subchondral bone. Current treatments include cell-based therapies but are frequently associated with donor-site morbidity. Our objective is to characterize the posterior process of the talus (SP) and the os trigonum (OT) tissues and investigate its potential as a new source of viable cells for application in tissue engineering and regenerative medicine.SP and OT tissues obtained from six patients were characterized by micro-computed tomography, and histological, histomorphometric and immunohistochemical analyses. Isolated cells proliferation and viability were evaluated by MTS assay, DNA quantification and Live/Dead staining. The TUNEL assay was performed to evaluate cell death by apoptosis. Moreover, the production of extracellular matrix was evaluated by toluidine blue staining, whereas cells phenotype was investigated by flow cytometry. Ankle explants characterization showed the presence of a cartilage tissue layer in both SP and OT tissues, which represent, at least 20% in average of the explant. The presence of type II collagen was detected in the extracellular matrix. Isolated cells presented a round morphology typical of chondrocytes. In in vitro studies, cells were viable and proliferating up to 21 days of culturing. No signs of apoptosis were detected. Flow cytometry analysis revealed that isolated cells maintained the expression of several chondrocytic markers during culturing. The results indicate that the SP and OT tissues are a reliable source of viable chondrocytes, which can find promising applications in ACI/MACI strategies with minimal concerns regarding donor zone complications.
publishDate 2017
dc.date.none.fl_str_mv 2017
2017-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/1822/38337
url http://hdl.handle.net/1822/38337
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Correia S. I., Silva-Correia J., Pereira H., Canadas R. F., da Silva Morais A., Frias A. M., Sousa R. A., Niek V. D. C., Espregueira-Mendes J. D., Reis R. L., Oliveira J. M. Posterior talar process as a suitable cell source for treatment of cartilage and osteochondral defects of the talus, Journal of Tissue Engineering and Regenerative Medicine, doi:10.1002/term.2092, 2017
1932-7005
10.1002/term.2092
26510640
http://onlinelibrary.wiley.com/doi/10.1002/term.2092/abstract
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Wiley
publisher.none.fl_str_mv Wiley
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799132538209304576